A record of what Ankush Bajaj said publicly, with the source. Not advice.
“Bullish on Laurus Labs, recommending a buy at ₹602 with targets of ₹680-705 and a stop loss at ₹555. The pharma and healthcare sector is performing well, and this stock is expected to rally in the near term.”
Ankush Bajaj’s track record (trackable calls only): 473 graded calls · 95% CI 39–48%
How this call is judged
A call is judged on closing prices only: a close at its target is a hit and a close at its stop is a miss. A call that states an entry starts at the first close that reaches it; if none does in the days allowed, it was never triggered, is not graded and counts toward no hit rate. No time frame is stated and the call gives both a target and a stop, so it is tracked until a close reaches one of them (rule H6): the target first is a hit, the stop first a miss, and until then it stays open.
Entry: ₹602, as stated.
Target ₹680, stop ₹555, as stated.
No time frame is stated, so it is tracked until a close reaches ₹680 or ₹555: there is no fixed window.
The stop ₹555 was reached on a close before the target ₹680. Miss.
The grader’s working: R3 TRADE_SETUP: entered ₹599.55 on 2025-01-06 (stated entry ₹602, DIP_LIMIT entry, filled); stop ₹555 breached at close ₹534.65 on 2025-01-27. No time frame is stated and the call gives both a target and a stop, so it is tracked until a close reaches one of them (rule H6): the target first is a hit, the stop first a miss, and until then it stays open.